Cargando…

Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study

Detalles Bibliográficos
Autores principales: Thein, Kyaw Z., Fu, Siqing, Janku, Filip, Tsimberidou, Apostolia M., Piha-Paul, Sarina A., Karp, Daniel D., Shah, Jatin, Milton, Denái R., Gong, Jing, Sulovic, Selma, McQuinn, Lacey, Stephen, Bettzy A., Colen, Rivka R., Carter, Brett W., Meric-Bernstam, Funda, Naing, Aung
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Innovative Healthcare Institute 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138422/
https://www.ncbi.nlm.nih.gov/pubmed/35663832
http://dx.doi.org/10.36401/JIPO-21-20
_version_ 1784714621503930368
author Thein, Kyaw Z.
Fu, Siqing
Janku, Filip
Tsimberidou, Apostolia M.
Piha-Paul, Sarina A.
Karp, Daniel D.
Shah, Jatin
Milton, Denái R.
Gong, Jing
Sulovic, Selma
McQuinn, Lacey
Stephen, Bettzy A.
Colen, Rivka R.
Carter, Brett W.
Meric-Bernstam, Funda
Naing, Aung
author_facet Thein, Kyaw Z.
Fu, Siqing
Janku, Filip
Tsimberidou, Apostolia M.
Piha-Paul, Sarina A.
Karp, Daniel D.
Shah, Jatin
Milton, Denái R.
Gong, Jing
Sulovic, Selma
McQuinn, Lacey
Stephen, Bettzy A.
Colen, Rivka R.
Carter, Brett W.
Meric-Bernstam, Funda
Naing, Aung
author_sort Thein, Kyaw Z.
collection PubMed
description
format Online
Article
Text
id pubmed-9138422
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Innovative Healthcare Institute
record_format MEDLINE/PubMed
spelling pubmed-91384222022-06-04 Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study Thein, Kyaw Z. Fu, Siqing Janku, Filip Tsimberidou, Apostolia M. Piha-Paul, Sarina A. Karp, Daniel D. Shah, Jatin Milton, Denái R. Gong, Jing Sulovic, Selma McQuinn, Lacey Stephen, Bettzy A. Colen, Rivka R. Carter, Brett W. Meric-Bernstam, Funda Naing, Aung J Immunother Precis Oncol Brief Reports Innovative Healthcare Institute 2022-02-09 /pmc/articles/PMC9138422/ /pubmed/35663832 http://dx.doi.org/10.36401/JIPO-21-20 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/This work is published under a CC-BY-NC-ND 4.0 International License.
spellingShingle Brief Reports
Thein, Kyaw Z.
Fu, Siqing
Janku, Filip
Tsimberidou, Apostolia M.
Piha-Paul, Sarina A.
Karp, Daniel D.
Shah, Jatin
Milton, Denái R.
Gong, Jing
Sulovic, Selma
McQuinn, Lacey
Stephen, Bettzy A.
Colen, Rivka R.
Carter, Brett W.
Meric-Bernstam, Funda
Naing, Aung
Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
title Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
title_full Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
title_fullStr Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
title_full_unstemmed Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
title_short Selinexor in Combination with Carboplatin and Pemetrexed in Patients with Advanced or Metastatic Solid Tumors: Results of an Open-Label, Single-Center, Multi-Arm Phase 1b Study
title_sort selinexor in combination with carboplatin and pemetrexed in patients with advanced or metastatic solid tumors: results of an open-label, single-center, multi-arm phase 1b study
topic Brief Reports
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9138422/
https://www.ncbi.nlm.nih.gov/pubmed/35663832
http://dx.doi.org/10.36401/JIPO-21-20
work_keys_str_mv AT theinkyawz selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT fusiqing selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT jankufilip selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT tsimberidouapostoliam selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT pihapaulsarinaa selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT karpdanield selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT shahjatin selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT miltondenair selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT gongjing selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT sulovicselma selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT mcquinnlacey selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT stephenbettzya selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT colenrivkar selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT carterbrettw selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT mericbernstamfunda selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy
AT naingaung selinexorincombinationwithcarboplatinandpemetrexedinpatientswithadvancedormetastaticsolidtumorsresultsofanopenlabelsinglecentermultiarmphase1bstudy